Activity value 93pakistan Buyer&Supplier,Last transaction date:
2026-04-30Address: house # 593-b, street # 10, chaklala scheme iii rawalpindi,pakistan
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for genome pharmaceutcals pvt ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 90 transactions, with a transaction quantity of 25917.99 and a transaction weight of 0.
5astarpharm ltd.
chinasupplier,they trade on 2025-12-30
471.27%
>
+View All
Products
Total 486
ProductsTransactionsPerDetail
pharmaceutical raw material 32743.72%>
bat 23331.15%>
origin india 17623.53%>
ail 9612.83%>
drum 9212.3%>
+View All
Hscode rank
Total 223
HSCode NameTransactionsPerDetail
HS 29339990729.63%>
HS 29333990618.16%>
HS 29183000608.02%>
HS 29349990577.62%>
HS 29335990466.15%>
+View All
Trading Area
Total 27
AreaTransactionsPerDetail
india104428.29%>
other102127.66%>
costa rica68018.42%>
china37710.21%>
england631.71%>
+View All
Port statistics
Total 37
Port NameTransactionsPerDetail
ipaf52114.12%>
islamabad2236.04%>
rpaf2226.01%>
raiw2115.72%>
new islamabad airfreight unit imports1945.26%>
+View All
genome pharmaceutcals pvt ltd. is pakistan Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,bat,origin india.
According to the 52wmb.com global trade database, as of 2026-04-30, the company has completed 3691 international trades,
with its main trading regions covering india,other,costa rica etc.
The core products include HS29339990,HS29333990,HS29183000 etc,
often transported via ipaf,port islamabad, port rpaf etc,
and its main trading partners are hangzhou maytime bio technologies co.ltd.,zeon pharma industries pvt ltd,zeon health jindustries.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on genome pharmaceutcals pvt ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.